For CETN2, MKI67, ARL13B, and SETDB1, patients with high expression experienced a worse OS, while high expression of CALN1, ELAVL3, ADCY3, SYN2, ARL13B, SLC12A5, and SOD1 were associated with better overall survival among patients with GBM. This evidence concerns the gene SLC12A5 and glioblastoma.